Literature DB >> 10213472

Influence of MPP+ on the state of tubulin polymerisation in NGF-differentiated PC12 cells.

G Cappelletti1, M G Maggioni, R Maci.   

Abstract

Cytoskeletal proteins have been reported as constituents of cytoplasmic inclusions typical of degenerated neurones in Parkinson's disease and, in addition, the involvement of cytoskeleton in the mechanism of action of the parkinsonism-producing neurotoxin MPP+ is emerging. Here we investigate the influence of MPP+ on the dynamic behaviour of microtubules. Neurone-like cells derived from a rat pheochromocytoma cell line (PC12) and differentiated with nerve growth factor are used as a model system. We found that sublethal doses of the neurotoxin markedly affect the state of tubulin polymerisation: polymerised tubulins significantly decreased, whereas an increase of unpolymerised alpha-tubulin was observed. Since the concentration of unassembled tubulin directly regulates tubulin synthesis by a feedback mechanism, we studied alpha- and beta-tubulin synthesis by metabolic labelling of PC12 cells with [35S] methionine and following immunoprecipitations. The results showed the significant decrease of labelling in both the microtubule subunits in cells exposed to the neurotoxin. We suggest that the MPP+-induced imbalance of tubulin polymerisation and synthesis represents a novel early step in the mechanism of action of the neurotoxin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213472     DOI: 10.1002/(SICI)1097-4547(19990401)56:1<28::AID-JNR4>3.0.CO;2-2

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  Altered time course of mRNA expression of alpha tubulin in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP).

Authors:  T V Damodaran; A Abdel-Rahman; M B Abou-Donia
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 2.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 3.  Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.

Authors:  Kurt R Brunden; Virginia M-Y Lee; Amos B Smith; John Q Trojanowski; Carlo Ballatore
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

4.  Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.

Authors:  Se Joon Choi; Anne Panhelainen; Yvonne Schmitz; Kristin E Larsen; Ellen Kanter; Min Wu; David Sulzer; Eugene V Mosharov
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

5.  Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.

Authors:  Yong Ren; Jinghui Zhao; Jian Feng
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

6.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.

Authors:  Sofia A Oliveira; William K Scott; Fengyu Zhang; Jeffrey M Stajich; Kenichiro Fujiwara; Michael Hauser; Burton L Scott; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-06-08       Impact factor: 2.660

7.  The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress.

Authors:  Nina G Bauer; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 2.866

8.  Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.

Authors:  A R Esteves; D M Arduíno; D F F Silva; C R Oliveira; S M Cardoso
Journal:  Parkinsons Dis       Date:  2011-01-16

9.  Parkinson mice show functional and molecular changes in the gut long before motoric disease onset.

Authors:  Manuela Gries; Anne Christmann; Steven Schulte; Maximilian Weyland; Stephanie Rommel; Monika Martin; Marko Baller; Ralph Röth; Stefanie Schmitteckert; Marcus Unger; Yang Liu; Frederik Sommer; Timo Mühlhaus; Michael Schroda; Jean-Pierre Timmermans; Isabel Pintelon; Gudrun A Rappold; Markus Britschgi; Hilal Lashuel; Michael D Menger; Matthias W Laschke; Beate Niesler; Karl-Herbert Schäfer
Journal:  Mol Neurodegener       Date:  2021-06-02       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.